CH625221A5 - - Google Patents

Download PDF

Info

Publication number
CH625221A5
CH625221A5 CH1516377A CH1516377A CH625221A5 CH 625221 A5 CH625221 A5 CH 625221A5 CH 1516377 A CH1516377 A CH 1516377A CH 1516377 A CH1516377 A CH 1516377A CH 625221 A5 CH625221 A5 CH 625221A5
Authority
CH
Switzerland
Prior art keywords
phenoxypyridine
monosulfate
stimulation
self
animals
Prior art date
Application number
CH1516377A
Other languages
English (en)
French (fr)
Inventor
Donald Eugene Butler
Original Assignee
Parke Davis & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis & Co filed Critical Parke Davis & Co
Publication of CH625221A5 publication Critical patent/CH625221A5/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
CH1516377A 1976-12-17 1977-12-09 CH625221A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75193376A 1976-12-17 1976-12-17

Publications (1)

Publication Number Publication Date
CH625221A5 true CH625221A5 (de) 1981-09-15

Family

ID=25024143

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1516377A CH625221A5 (de) 1976-12-17 1977-12-09

Country Status (24)

Country Link
US (1) US4128555A (de)
JP (1) JPS5953909B2 (de)
AR (1) AR217458A1 (de)
AT (1) AT358038B (de)
AU (1) AU510436B2 (de)
BE (1) BE861649A (de)
CA (1) CA1060021A (de)
CH (1) CH625221A5 (de)
DE (1) DE2755016A1 (de)
DK (1) DK146387C (de)
ES (1) ES464922A1 (de)
FR (1) FR2392009A1 (de)
GB (1) GB1559918A (de)
GR (1) GR64011B (de)
HK (1) HK9184A (de)
HU (1) HU176300B (de)
IL (1) IL53579A0 (de)
MX (1) MX4520E (de)
NZ (1) NZ185930A (de)
PH (1) PH13387A (de)
PT (1) PT67386B (de)
SE (1) SE431542B (de)
YU (1) YU40021B (de)
ZA (1) ZA777359B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218238A (en) * 1978-06-19 1980-08-19 Eli Lilly And Company Herbicidal 1-alkyl-3-phenylpyridinium salts
US4174209A (en) * 1978-06-19 1979-11-13 Eli Lilly And Company Herbicidal 1-alkyl-3-phenylpyridinium salts
US4434169A (en) * 1983-01-03 1984-02-28 Warner-Lambert Company Pharmaceutical compositions and methods
US4666926A (en) * 1986-02-27 1987-05-19 Warner-Lambert Company Transdermal formulations
US5232934A (en) * 1992-07-17 1993-08-03 Warner-Lambert Co. Method for the treatment of psychomotor stimulant addiction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2753352A (en) * 1953-01-14 1956-07-03 Olin Mathieson Derivatives of isonicotinic acid hydrazide
CH434868A (de) * 1964-02-10 1967-04-30 Ciba Geigy Schädlingsbekämpfungsmittel

Also Published As

Publication number Publication date
JPS5953909B2 (ja) 1984-12-27
DK549677A (da) 1978-06-18
AT358038B (de) 1980-08-11
PT67386B (en) 1979-05-18
DE2755016A1 (de) 1978-06-29
ZA777359B (en) 1979-07-25
SE431542B (sv) 1984-02-13
GB1559918A (en) 1980-01-30
HK9184A (en) 1984-02-10
PH13387A (en) 1980-03-25
ATA880377A (de) 1980-01-15
PT67386A (en) 1978-01-01
BE861649A (fr) 1978-03-31
FR2392009A1 (fr) 1978-12-22
DK146387B (da) 1983-09-26
SE7714012L (sv) 1978-06-18
HU176300B (en) 1981-01-28
DE2755016C2 (de) 1988-02-25
ES464922A1 (es) 1978-09-01
GR64011B (en) 1980-01-18
NZ185930A (en) 1979-08-31
MX4520E (es) 1982-06-02
YU40021B (en) 1985-06-30
IL53579A0 (en) 1978-03-10
AU510436B2 (en) 1980-06-26
DK146387C (da) 1984-03-05
AU3141777A (en) 1979-06-14
YU289477A (en) 1982-08-31
US4128555A (en) 1978-12-05
FR2392009B1 (de) 1980-04-04
JPS5377068A (en) 1978-07-08
CA1060021A (en) 1979-08-07
AR217458A1 (es) 1980-03-31

Similar Documents

Publication Publication Date Title
LU82386A1 (fr) Amides d'acyl-carnitines,leur procede de preparation et compositions pharmaceutiques contenant ces amides
CH647757A5 (fr) Derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee.
BE834794A (fr) Acide 3-trihydroxygermano-propionique
O Bryzgalov et al. Lappaconitine: influence of halogen substituent on the antiarrhythmic activity
FR2665701A1 (fr) Agents de blocage neuromusculaire.
FR3107897A1 (fr) Dérivés de nicotinamide mononucléotides
JP2006513222A (ja) アドレナリン性β受容体およびホスホジエステラーゼに対する抑制活性を有する強心性化合物
CH625221A5 (de)
EP0094283B1 (de) Arzneimittelform von Theophyllin mit verlängerter Wirkung
FR2963790A1 (fr) Docosahexaeneoate de panthenyle et son utilisation dans le traitement et la prevention des maladies cardiovasculaires
FR2514006A1 (fr) Acylamino-4 aza-1 adamantanes, procede pour leur preparation, et application en therapeutique
RU2663836C1 (ru) L-Энантиомер 2-этил-6-метил-3-гидроксипиридиния гидроксибутандиоата, обладающий церебропротекторной активностью
CA2384525C (en) Thienylhydrazon with digitalis-like properties (positive inotropic effects)
JPH0580452B2 (de)
CA1327582C (fr) Derive de la dihydro-1,4 pyridine denomme (-){[(amino-2 ethoxy)-2 ethoxy]methyl}-2(dichloro-2,3 phenyl)-4 ethoxycarbonyl-3 methoxycarbonyl-5 methyl-6 dihydro-1,4 pyridine, son procede de preparation et les compositions pharmaceutiques qui le contiennent
US7091238B1 (en) Thienylhydrazon with digitalis-like properties (positive inotropic effects)
JP7338877B2 (ja) 心臓アセチルコリン産生能誘導薬
FR2465722A1 (fr) 3-(hydroxy ou hydroxymethyl)-5-(4-pyridinyl)-2(1h)-pyridinones, leur preparation et leur utilisation comme agents cardiotoniques
CH628321A5 (en) Process for the preparation of derivatives of isobutyramide and medical composition containing these derivatives
FR2471380A1 (fr) 6-(pyridinyl)-pyridazines, leur preparation et leur utilisation therapeutique
LU83775A1 (fr) Derives de naphtyridine,leur preparation et leur application en therapeutique
BE853144A (fr) Derive nouveau de la pyridine, procede pour sa composition pharmaceutique contenant ce derive
CH654834A5 (fr) Derive de l'isopropylamino pyrimidine, procede pour sa preparation et composition therapeutique contenant ce derive.
EP0200583A1 (de) 7-Hydroxy-Indolderivate, ihre Salze, Verfahren zur Herstellung, Anwendung als Heilmittel, Zusammensetzungen die sie enthalten und Zwischenprodukte
FR2543954A1 (fr) Acylamino-4 aza-1 adamantanes, procede pour leur preparation et application en therapeutique

Legal Events

Date Code Title Description
PL Patent ceased